Article

Nidek, Mercy Ships partner to treat poor

Fremont, CA-Nidek Inc. will lend its YC-1600 Nd:YAG ophthalmic laser to Mercy Ships International to treat the poor in developing nations.

Related Videos
Arun Gulani, MD: How the Gni instrument enhances precision and control in cataract surgery
EyeCon 2024: Peter J. McDonnell, MD, marvels on mentoring, modern technology, and ophthalmology’s future
EyeCon Co-chair Oluwatosin U. Smith, MD: Passion for Research and Education Drives Her Commitment to Ophthalmology
Dr. SriniVas Sadda Discusses Vision for ARVO as New President: Collaboration, Funding Challenges, and Impact of Annual Meetings
Highlights from the 18th Annual Controversies in Modern Eye Care Symposium: Arjan Hura, MD, on Refractive Surgery, Retina Care, and Record Attendance
ASCRS 2024: ViaLase Updates on Nonincisional Glaucoma Treatment Targeting Trabecular Meshwork
Dr. Neda Nikpoor Shares Practical Techniques to Combat Unconscious Gender Bias and Promote Gender Equality in Ophthalmology
ASCRS 2024: George O. Waring, MD, shares early clinical performance of bilateral Odyssey implantation
ASCRS 2024: Deborah Gess Ristvedt, DO, discusses third-generation trabecular micro-bypass
Related Content
Multidisciplinary team secures multimillion-dollar award to fund research to achieve a functional human eye transplant
December 3rd 2024

Multidisciplinary team secures multimillion-dollar award to fund research to achieve a functional human eye transplant

Ehsan Sadri, MD, leads an ophthalmology innovation discussion with Jeffry Weinhuff of Visionary Ventures
March 29th 2024

(EyePod) From idea to impact: Navigating ophthalmic innovation

Mazava Project shines light on blindness in Madagascar
November 16th 2024

Mazava Project shines light on blindness in Madagascar

EyePod: Integrating cutting-edge pipeline devices for enhanced cataract surgery
December 19th 2023

EyePod: Integrating cutting-edge pipeline devices for enhanced cataract surgery

Formosa Pharmaceuticals announces top-line results from Chinese trial evaluating APP13007
November 6th 2024

Formosa Pharmaceuticals announces top-line results from Chinese trial evaluating APP13007

Study: Aromatherapy decreased postoperative patient anxiety and pain associated with oculoplastic surgery
November 6th 2024

Study: Aromatherapy decreased postoperative patient anxiety and pain associated with oculoplastic surgery

© 2024 MJH Life Sciences

All rights reserved.